Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. AHA: Nearly Half of U.S. Adults […]
Read More
TEL AVIV (Reuters) – Bristol-Myers Squibb Co and Israel’s Compugen said on Thursday...
Read More
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Helmets May Not Protect Skiers From Traumatic […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in Nursing for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Ground Chuck Products Recalled by Publix Super Markets […]
Read More
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Ground Chuck Products Recalled by […]
Read More